Key result
Shared 3-gene panel links hypothyroidism to essential hypertension with an AUC of ~0.74.
Why the study?
Thyroid dysfunction contributes to arterial hypertension, but the evidence is inconsistent and the transcriptomic overlap between the hypothyroid state and hypertension in peripheral blood remained unmapped.
This integrative in silico transcriptomic analysis identifies a modest, hypothesis-generating overlap between the hypothyroid state and essential hypertension in peripheral blood centered on inflammatory and angiogenic signaling hubs (STAT3, IL6R, and VEGFA).
Answers are grounded in this paper and cite their sources.
Supports shared molecular pathways in hypothyroidism and hypertension; hypothesis-generating and should not yet alter clinical practice.
Introduction: Thyroid dysfunction contributes to arterial hypertension, but the evidence is inconsistent and their transcriptomic overlap remains unmapped. Objective: To identify transcriptomic signatures shared by the hypothyroid state and arterial hypertension in peripheral blood and to define candidate molecular hubs. Methods: This in silico analysis used public Gene Expression Omnibus data: GSE103305 (whole blood; eight athyroid patients, hypothyroid versus levothyroxine-replete) and GSE75360 (mononuclear cells; 10 hypertensive, 11 normotensive), with GSE24752 and GSE74144 for sensitivity analyses. Differentially expressed genes (FDR < 0.05; |log2 fold change| ≥ 0.585) were identified with DESeq2 and limma and intersected. Weighted gene co-expression network analysis, STRING networks (score ≥ 0.700), cytoHubba ranking, enrichment, and receiver operating characteristic analysis followed. Results: The thyroid and hypertension signatures comprised 486 and 173 genes and shared 19 (P = 0.0032); 14 (74%) were concordant in direction. Eleven shared genes were also candidate co-expression hubs, forming a nine-node STRING network in which STAT3, IL6R, and VEGFA ranked highest. The shared signature was enriched for JAK-STAT signaling (FDR = 0.008). STAT3 and IL6R, but not VEGFA, were dysregulated in additional hypertension datasets (P < 0.05). A three-gene panel yielded an area under the curve of 0.74 (95% CI, 0.61-0.86) in the discovery cohort and 0.69 (95% CI, 0.55-0.82) in GSE74144. Conclusion: The hypothyroid state and hypertension share a modest inflammatory and angiogenic transcriptomic signature in peripheral blood involving STAT3, IL6R, and VEGFA. These hubs are hypothesis-generating and need validation in larger cohorts.
No takes yet. Share an insight, caveat, or question.
Andrade et al. (2026) studied Hypothyroidism and systemic arterial hypertension (n=29). Hypothyroid state and essential hypertension vs. Levothyroxine-replete (euthyroid) and normotensive controls was evaluated on Shared differentially expressed genes between hypothyroid state and essential hypertension in peripheral blood (19 shared genes (74% concordant); 3-gene panel AUC 0.74, 95% CI 0.61-0.86, p=0.0032). The hypothyroid state and essential hypertension shared 19 differentially expressed peripheral blood genes, with a 3-gene hub panel (STAT3, IL6R, VEGFA) yielding an AUC of 0.74.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: